Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy.

Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy.
复制标题

DOI:
10.1126/sciadv.abk0052
复制
发表时间:
2022-02-25
期刊:
影响因子:
13.6
通讯作者:
Mestroni L
Mestroni L
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Chen SN;Lam CK;Wan YW;Gao S;Malak OA;Zhao SR;Lombardi R;Ambardekar AV;Bristow MR;Cleveland J;Gigli M;Sinagra G;Graw S;Taylor MRG;Wu JC;Mestroni L

文献摘要

参考文献

被引文献

相似文献

FLNC截断突变(FlnCtv)是遗传性扩张型心肌病(DCM)的常见原因,具有发展为心律失常性心肌病的高风险。我们利用患者特异性诱导的多能干细胞来源的心肌细胞(IPSC-CMS)研究了突变的FlnC在致心律失常的扩张性心肌病(a-DCM)发病中的分子机制。我们证明了来自两个具有不同FLNCtv突变的患者的IPSC-CMS表现出心律失常和收缩受损。FLNC消融诱导了类似的表型,表明FLNCtv是功能丧失的突变。免疫共沉淀和蛋白质组学分析证实β-连环蛋白(CTNNB1)是其下游靶基因。FlnC缺乏导致CTNNB1核移位,随后激活了血小板衍生生长因子受体α(PDGFRA)途径,在a-DCM和FlNCtv患者的心脏中也观察到了这一现象。使用PDGFRA抑制剂crenolanib治疗可以改善IPSC-CMS患者的收缩功能。综上所述,我们的研究结果表明PDGFRA信号与发病机制有关,抑制这一通路是治疗FLNC相关心肌病的一种潜在策略。FlnC缺乏激活细胞间的黏附/CTNNB1/PDGFRA,导致心律失常;用crenolanib抑制挽救表型。
FLNC truncating mutations (FLNCtv) are prevalent causes of inherited dilated cardiomyopathy (DCM), with a high risk of developing arrhythmogenic cardiomyopathy. We investigated the molecular mechanisms of mutant FLNC in the pathogenesis of arrhythmogenic DCM (a-DCM) using patient-specific induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs). We demonstrated that iPSC-CMs from two patients with different FLNCtv mutations displayed arrhythmias and impaired contraction. FLNC ablation induced a similar phenotype, suggesting that FLNCtv are loss-of-function mutations. Coimmunoprecipitation and proteomic analysis identified β-catenin (CTNNB1) as a downstream target. FLNC deficiency induced nuclear translocation of CTNNB1 and subsequently activated the platelet-derived growth factor receptor alpha (PDGFRA) pathway, which were also observed in human hearts with a-DCM and FLNCtv. Treatment with the PDGFRA inhibitor, crenolanib, improved contractile function of patient iPSC-CMs. Collectively, our findings suggest that PDGFRA signaling is implicated in the pathogenesis, and inhibition of this pathway is a potential therapeutic strategy in FLNC-related cardiomyopathies. FLNC deficiency activates cell-cell adhesion/CTNNB1/PDGFRA, causing arrhythmias; inhibition with crenolanib rescues the phenotype.
河马途径被激活,是心律失常性心肌病中脂肪形成的因果机制。
DOI: 10.1161/circresaha.114.302810
发表时间: 2014-01-31
影响因子: 20.1
作者:
Chen SN;Gurha P;Lombardi R;Ruggiero A;Willerson JT;Marian AJ
通讯作者: Marian AJ
DOI: 10.1007/s00401-012-1054-9
发表时间: 2013-01
影响因子: 12.7
作者:
Fürst DO;Goldfarb LG;Kley RA;Vorgerd M;Olivé M;van der Ven PF
通讯作者: van der Ven PF
DOI: 10.1016/0092-8674(94)90069-8
发表时间: 1994-12-02
期刊: CELL
影响因子: 64.5
作者:
HEASMAN, J;CRAWFORD, A;WYLIE, C
通讯作者: WYLIE, C
DOI: 10.1038/nmeth.2999
发表时间: 2014-08
期刊: NATURE METHODS
影响因子: 48
作者:
Burridge, Paul W.;Matsa, Elena;Shukla, Praveen;Lin, Ziliang C.;Churko, Jared M.;Ebert, Antje D.;Lan, Feng;Diecke, Sebastian;Huber, Bruno;Mordwinkin, Nicholas M.;Plews, Jordan R.;Abilez, Oscar J.;Cui, Bianxiao;Gold, Joseph D.;Wu, Joseph C.
通讯作者: Wu, Joseph C.
DOI: 10.7554/elife.21172
发表时间: 2017-01-18
期刊: eLife
影响因子: 7.7
作者:
Bloomekatz J;Singh R;Prall OW;Dunn AC;Vaughan M;Loo CS;Harvey RP;Yelon D
通讯作者: Yelon D